CRANBURY, N.J.--(BUSINESS WIRE)--MD Magazine®, a digital platform that focuses on providing physicians with the most valuable and up-to-date specialty- and disease-specific resources to help them deliver the best patient care, is proud to announce the addition of Rare Disease Report® to its online platform.
“We are pleased to announce that Rare Disease Report® has found a new home with MD Mag,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of MD Magazine®. “We look forward to sharing this with our MD Mag community.”
The online addition of Rare Disease Report® will provide MD Mag with clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, videos, and other content in the rare disease space. Clinicians interested in rare diseases will be treated to MD Mag’s brand of breaking news reporting, up-to-date clinical coverage and expert perspectives.
Here is some of the newest Rare Disease Report® content to appear on MD Mag:
- ALS Gene Expression Atlas Could Provide New Disease Insights
- Benralizumab as a Treatment for Hypereosinophilic Syndromes
- FDA Designates PRM-151 Breakthrough Therapy for Idiopathic Pulmonary Fibrosis
About MD Magazine®
MD Magazine® is a comprehensive clinical news and information portal that provides physicians and other health care professionals with up-to-date specialty- and disease-specific resources designed to help them deliver better care to patients. Readers have access to breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight, and analysis from physician contributors and other resources. MD Magazine® is part of MJH Associates, Inc., the largest privately held, independent full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.